Business

This archive collects stories about businesses — from startups and local enterprises to multinational corporations — taking meaningful action on social, environmental, and economic challenges. These reports highlight moments when commerce and accountability intersect in constructive ways.

Hens walking freely in a bright cage-free barn for an article about cage-free egg pledges

Over 1,400 companies worldwide have made cage-free egg pledges

By / / Good News For Humankind

Cage-free egg commitments are reshaping the global food industry, with more than 1,400 companies now pledging to eliminate conventional battery cages from their supply chains. Many of those deadlines fall in 2025, turning corporate promises into real changes for hundreds of millions of hens worldwide. Cage-free systems allow hens to walk, perch, nest, and spread their wings — basic behaviors impossible in battery cages smaller than a sheet of paper. What makes this significant is that coordinated advocacy, not government regulation, drove the shift by targeting major buyers and tracking compliance publicly.

Chevron gas station located near a Louisiana wetlands restoration project site along the coast, for article on Louisiana wetlands restoration

Chevron ordered to pay $740 million to restore Louisiana coast in landmark trial

By / / Good News For Humankind

Louisiana wetlands just got a powerful new defender: a jury ordered Chevron to pay $744.6 million to restore marshland in Plaquemines Parish, with interest pushing the total past $1.1 billion. Jurors found that Texaco, which Chevron acquired in 2001, had spent decades dredging canals and dumping wastewater into the marsh without meaningful cleanup. The ruling matters far beyond one rural parish — it’s the first of dozens of similar cases to reach trial, and the communities on this vanishing coast are disproportionately Black, Indigenous, and low-income. As courts from Europe to the Americas increasingly hold polluters accountable, this verdict signals that coastal destruction is no longer just a political fight. It’s a legal one.

A doctor reviewing a prescription pad in a clinical setting for an article about non-opioid pain drug approval

FDA approves first non-opioid pain drug in more than 20 years

By / / Good News For Humankind

The FDA’s approval of Journavx (suzetrigine), a first-in-class non-opioid pain drug, marks the most significant shift in acute pain treatment in over two decades. Developed by Vertex Pharmaceuticals, the drug blocks a specific sodium channel in the peripheral nervous system, stopping pain signals before they reach the brain without engaging the opioid pathways linked to addiction and overdose. Two rigorous clinical trials confirmed its effectiveness for moderate to severe acute pain. With more than 500,000 opioid overdose deaths in the U.S. since 1999, this approval offers patients and doctors a genuinely new choice — one that treats real pain without the shadow of dependence.

New York, for article on NYC offshore wind farm

New York City to get a $3 billion, 80,000-acre offshore wind farm

By / / Good News For Humankind

Offshore wind is coming to New York City for the first time, with Empire Wind 1 set to power roughly half a million residents by 2027. Developed by Equinor and backed by a $3 billion financing package, the 810 MW project will be the first to plug directly into the city’s grid — covering about 6% of NYC’s electricity needs. Construction will run through a redeveloped South Brooklyn Marine Terminal, creating more than 1,000 union jobs along the waterfront. It’s not a silver bullet, but it’s a working proof of concept: the largest U.S. city now has a real, physical link to clean ocean wind, and a template other coastal cities can follow.

Dongying floating solar farm, for article on offshore floating solar

China activates world’s largest offshore floating solar installation

By / / Good News For Humankind

Offshore floating solar just reached gigawatt scale: a fleet of 2,934 steel-truss platforms now sits eight kilometers off China’s Shandong coast, generating enough electricity each year to power roughly 2.6 million urban residents. Activated in November 2024, the Dongying farm is the largest installation of its kind ever built, anchored to withstand storms and saltwater in the Bohai Sea. Moving panels out to sea sidesteps the fierce competition for land that solar faces nearly everywhere, and the cooler ocean environment can actually help panels run more efficiently. As countries hunt for clean power without paving over farmland or forests, the ocean is starting to look less like an obstacle and more like the next great frontier.

Blood cells under microscope, for article on smart insulin, for article on lab-grown blood cells

Danish scientists design new form of insulin that automatically switches itself on and off

By / / Good News For Humankind

Smart insulin that reads blood sugar in real time and adjusts its own activity has cleared a major hurdle in animal trials, according to Danish researchers publishing in Nature. The molecule switches on when glucose climbs and powers down as levels normalize, mimicking the feedback loop of a healthy pancreas. That matters because conventional insulin can overshoot and trigger dangerously low blood sugar, a side effect that endangers people living with diabetes every day. Scientists have chased this idea for more than 40 years, and earlier candidates kept stumbling in living bodies. For the more than 500 million people worldwide managing diabetes, an insulin that doses itself would be a quiet revolution — bringing daily care closer to how the body was meant to work.

Virus up close, for article on lenacapavir HIV prevention

‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries

By / / Good News For Humankind

Lenacapavir, a twice-yearly HIV prevention shot with near-perfect results in clinical trials, is about to become far more affordable for millions of people. Gilead Sciences has licensed six generic manufacturers across India, Egypt, Pakistan, and the U.S. to produce the drug for 120 lower-income countries, where researchers estimate it could eventually be made for as little as $40 per patient per year. In trials among cisgender women in South Africa and Uganda, not a single participant who received the injection contracted HIV. Advocates are urging wider access, since much of Latin America was left out of the deal. Still, it’s a hopeful signal that breakthrough prevention tools can reach the people who need them most — fast.

image for article on mpox diagnostic test

World Health Organization approves first mpox diagnostic test for emergency use

By / / Good News For Humankind

The first mpox diagnostic test has been cleared through the World Health Organization’s Emergency Use Listing, opening a faster procurement route for the countries hit hardest by the outbreak. Abbott’s Alinity m MPXV assay detects both clades of the virus from rash samples, and UN agencies can now order it directly for places where national approval pathways would otherwise take months. That speed matters: in 2024, only 37% of suspected mpox cases in the Democratic Republic of the Congo were confirmed by testing, leaving outbreaks harder to trace. Three more tests are already under WHO review, with more manufacturers in talks. It’s a hopeful signal that the world is learning from past pandemics — building diverse, quality-assured tools before bottlenecks become catastrophes.

Aerial view of large solar farm, for article on Gulf solar projects

Qatar and Saudi Arabia announce four mammoth new solar projects totaling 7.5GW

By / / Good News For Humankind

Solar power is gaining serious ground in the Gulf, with Qatar and Saudi Arabia together unveiling four new photovoltaic projects totaling 7.5 gigawatts — enough capacity to power several million homes once online before 2030. That two of the world’s biggest oil producers are pouring this much into sunlight says something striking about where the economics now point. Saudi Arabia is aiming for half its electricity from renewables by decade’s end, and Qatar is building in parallel, joining neighbors like the UAE and Morocco already deep into their own clean energy buildouts. When petrostates start constructing gigawatt-scale solar, it’s a signal the global energy transition has crossed a threshold that even the old fossil fuel order can no longer ignore.

Medical researcher in a lab examining vials related to asthma and COPD treatment and mRNA vaccine development, for article on benralizumab injection, for article on mRNA lung cancer vaccine

World’s first mRNA lung cancer vaccine enters human trials in seven countries

By / / Good News For Humankind

A landmark mRNA lung cancer vaccine is now being tested in human patients for the first time, marking a historic milestone in cancer treatment. BNT116, developed by BioNTech, uses the same messenger RNA technology behind COVID-19 vaccines to train the immune system to recognize and destroy non-small cell lung cancer cells. The phase 1 trial spans 34 sites across seven countries, with roughly 130 patients enrolled. Unlike chemotherapy, this approach targets only tumor cells, potentially offering a more precise and lasting defense against the world’s deadliest cancer, which kills 1.8 million people annually.